6657 — Energenesis Biomedical Co Balance Sheet
0.000.00%
- TWD4.48bn
- TWD3.53bn
- TWD7.75m
Annual balance sheet for Energenesis Biomedical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 544 | 726 | 485 | 699 | 665 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.62 | 1.66 | 1.86 | 2.26 | 3.55 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 554 | 740 | 503 | 719 | 688 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 79.8 | 89 | 82.5 | 77.2 | 75.8 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 705 | 886 | 631 | 829 | 781 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 22.8 | 27.2 | 24.4 | 21.3 | 35.8 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 32.5 | 33.4 | 28.3 | 24.6 | 41.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 673 | 852 | 603 | 804 | 739 |
| Total Liabilities & Shareholders' Equity | 705 | 886 | 631 | 829 | 781 |
| Total Common Shares Outstanding |